Clinical trial
Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of…
NCT00247247 · Orion Corporation, Orion Pharma, Industry · Completed
Key facts
| NCT number | NCT00247247 |
|---|---|
| Title | Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off. |
| Official title | Efficacy and Tolerability of Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing-Off Phenomenon |
| Lead sponsor | Orion Corporation, Orion Pharma, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Comtess® |
| Enrollment | 300 |
| Start date | Dec 1, 2002 |
| Completion | Jun 1, 2005 |
| First posted | Nov 1, 2005 |
| Last update posted | Jun 25, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: